[1] Dooley S,Ten DP. TGF-β in progression of liver disease. Cell Tissue Res,2012,347（1）:245-256.
[2] 郑素军,邢欣悦,韩源平,等. TGF-β1对大鼠HSC-T6 细胞增殖、细胞周期和胶原分泌的影响.实用肝脏病杂志,2012,15（4）:327-331.
[3] Kreidl E,Oztürk D,Metzner T,et al. Activins and follistatins: Emerging roles in liver physiology and cancer. World J Hepatol,2009,1（1）:17-27.
[4] Jones CP,Gregory LG,Causton B,et al. Activin A and TGF-β promote T（H）9 cell-mediated pulmonary allergic pathology. J Allergy Clin Immunol,2012,129（4）:1000-1003.
[5] Moffatt MF,Gut IG,Demenais F,et al. A large-scale,consortium-based genomewide association study of asthma. N Engl J Med,2010,363 （13）:1211-1221.
[6] Lipardi C,Wei Q,Paterson B M. RNAi as random degradative PCR:siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs. Cell,2001,107（3）:297-307.
[7] 郑素军,林汝仙,夏云,等. KDR为靶的反义寡核苷酸、siRNA活性比较. 重庆医科大学学报,2005,30（3）:340-344,382.
[8] Caplen NJ,Parrish S,Imani F,et al. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci U S A,2001,98（17）:9742-9747.
[9] 夏云,林汝仙,郑素军,等. 靶向端粒酶逆转录酶（hTERT）RNAi载体的构建及活性评价. 生物化学与生物物理进展,2004,31（12）:1079-1084.
[10] 郑素军,夏云,任红,等. 端粒酶逆转录酶小干扰RNA对肝癌细胞的体外抑制作用. 中华肝脏病杂志,2004,12（9）:23-26.
[11] Zender L,Hutker S,Liedtke C,et al. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci U S A,2003,100（13）:7797-7802.
[12] Ying RS,Zhu C,Fan XG,et al. Hepatitis B virus is inhibited by RNA interference in cell culture and in mice. Antiviral Res,2007,73（1）:24-30.
[13] George J,Tsutsumi M. siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats. Gene Ther,2007,14（10）:790-803.
[14] Nishitsuji H,Kohara M,Kannagi M,et al. Effective suppression of human immunodeficiency virus type 1 through a combination of short-or long-hairpin RNAs targeting essential sequences for retroviral integration. J Virol,2006,80（15）:7658-7666.
[15] 陈鹏,郑素军,王世美,等. 靶向大鼠Smad3基因的siRNA筛选及其shRNA重组慢病毒的构建. 临床肝胆病杂志,2011,27（5）:533-537.
[16] 郑素军,邢欣悦,武聚山,等. Smad3 shRNA抑制TGFβ1对HSC-T6细胞活化的抗肝纤维化作用. 临床肝胆病杂志,2012,28（4）:289-295.
[17] 王世美,郑素军,邢欣悦,等. TGF-β1对大鼠肝细胞系BRL-3A凋亡和细胞周期的影响. 世界华人消化杂志,2011,19（16）：1659-1665.
[18] Ruwart MJ,Rush BD,Snyder KF,et al. 16,16-Dimethyl prostaglandin E2 delays collagen formation in nutritional injury in rat liver. Hepatology,1988,8（1）:61-64.
[19] Bataller R,Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis,2001,21（3）:437-451.
[20] Gressner AM,Weiskirchen R,Breitkopf K,et al. Roles of TGF-beta in hepatic fibrosis. Front Biosci,2002,7:d793-807.
[21] MacLean JJ,Roughley PJ,Monsey RD,et al. In vivo intervertebral disc remodeling:kinetics of mRNA expression in response to a single loading event. J Orthop Res,2008,26（5）:579-588.
[22] Sanderson N,Factor V,Nagy P,et al. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A,1995,92（7）:2572-2576.
[23] Chen YW,Li DG,Wu JX,et al. Tetrandrine inhibits activation of rat hepatic stellate cells stimulated by transforming growth factor-beta in vitro via up-regulation of Smad 7. J Ethnopharmacol,2005,100（3）:299-305.
[24] Kharbanda KK,Rogers DN,Wyatt TA,et al. Transforming growth factor-beta induces contraction of activated hepatic stellate cells. J Hepatol,2004,41（1）:60-66.
[25] Date M,Matsuzaki K,Matsushita M,et al. Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury. J Hepatol,2000,32（2）:251-260.
[26] Miyazaki T,Karube M,Matsuzaki Y,et al. Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachloride-induced hepatic fibrosis. J Hepatol,2005,43（1）:117-125. |
